MIER3 inhibitors constitute a chemical class targeting the MIER3 protein, known for its involvement in cellular signaling pathways. The discovery and optimization of these inhibitors utilize a combination of advanced research methodologies, including high-throughput screening, molecular docking, and both in vitro assays. The initial phase of identifying potential MIER3 inhibitors begins with high-throughput screening, where a vast library of chemical compounds is tested for their ability to bind to and inhibit MIER3. This screening is crucial for pinpointing compounds that exhibit the desired inhibitory activity. Following this, selected compounds are subjected to molecular docking studies. These computational analyses provide valuable insights into the interaction mechanisms between the inhibitors and MIER3, including details on binding affinities, interaction sites, and potential effects on the protein's conformation. Understanding these interaction dynamics is essential for refining the chemical structure of the inhibitors to enhance their specificity and potency against MIER3.
Subsequent to computational modeling, the biological efficacy and mechanism of action of MIER3 inhibitors are further explored through in vitro biochemical assays and in vivo studies. Techniques such as CRISPR-Cas9 gene editing are employed to manipulate MIER3 expression levels in cell lines, facilitating the observation of the inhibitors' effects in a controlled environment. Additionally, fluorescent imaging techniques, including the use of GFP-tagged MIER3, allow for the real-time visualization of the protein's behavior in the presence of inhibitors. These experimental approaches are instrumental in validating the inhibitory effects observed in computational models and provide a comprehensive understanding of how MIER3 inhibitors interact with their target. By integrating these diverse methodologies, researchers can systematically characterize MIER3 inhibitors, elucidating their potential to modulate the activity of MIER3 within cellular processes. This detailed exploration paves the way for further investigations into the biological implications of inhibiting MIER3, enhancing our understanding of its role in cellular signaling networks.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase, potentially affecting MIER3 by altering chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which may influence MIER3 activity through epigenetic modification of gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, potentially impacting MIER3 activity by changing the chromatin state and gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Inhibits histone deacetylase, potentially affecting MIER3 by altering gene expression through chromatin remodeling. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective inhibitor of class I histone deacetylases, could influence MIER3 by modulating gene expression. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
A histone deacetylase inhibitor, potentially impacting MIER3 activity by affecting gene transcription. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Inhibits histone deacetylase, which may indirectly affect MIER3 activity through epigenetic mechanisms. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, could influence MIER3 by altering DNA methylation and gene expression. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
A specific HDAC3 inhibitor, potentially affecting MIER3 by impacting gene regulation and expression. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Targets HDACs, potentially affecting MIER3 activity through alterations in gene expression. | ||||||